📰 Approves News
Page 33 - Approves News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Approves. Real-time updates on events, politics, business and more.
March 8, 2023
Natco Pharma Limited announced via an exchange filing, that the Board of Directors of the company at its meeting held on 8th March, 2023 has inter alia: 1. Approved a proposal to buyback by the Company of up to 30,00,000 fully paid-up equity shares of face value of Rs 2 each at a price not exceeding Rs 700 per Equity Share payable in cash for an aggregate amount not exceeding 210,00,00,000
March 7, 2023
Aamal general assembly approves distribution of 5% cash dividend
March 7, 2023
Power Grid Corporation of India Limited informed via an exchange filing, that the Board of Directors of the company in their meeting held on 6th March, 2023 have accorded Investment approvals for the following: 1. Eastern Region Expansion Scheme-XXIX at an estimated cost of Rs 524.04 cr scheduled to be commissioned by November, 2025;
March 6, 2023
EVelution Energy, a U.S. Electric Vehicle (EV) battery materials processing company, has received the unanimous approval of the Yuma County Board of Supervisors
March 3, 2023
ISLAMABAD (Reuters) -- Industrial and Commercial Bank of China on Friday approved a rollover of a $1.3 billion loan for cash-strapped Pakistan, which
March 2, 2023
IMF approves $114.8M emergency funding for South Sudan
March 2, 2023
TRIPOLI: Libya's High State Council voted on Thursday for a constitutional amendment intended to provide a basis for elections but there appeared to...
March 1, 2023
PARIS (dpa-AFX) - The U.S. Food and Drug Administration approved Kevzara (sarilumab) for the treatment of polymyalgia rheumatica, an inflammatory rheumatic disease, in adult patients who have had
March 1, 2023
MUSCAT: The State Council on Wednesday approved the draft water and sanitary drainage sector regulatory law referred to it from the Council of...
February 24, 2023
PARIS (dpa-AFX) - The U.S. Food and Drug Administration approved once-weekly Altuviiio, a new class of factor VIII therapy for hemophilia A that offers significant bleed protection, Sanofi - Aventis